Brief: Myriad Genetics Q1 EPS USD -0.36
05/05/2026 21:05
May 05 (Reuters) - Myriad Genetics Q1 revenue USD 200.4 million vs. IBES estimate USD 202.5 million. Q1 adjusted operating expenses USD 148.5 million Q1 gross margin 68.7% Q1 net income USD -34.1 million Q1 adjusted EPS USD -0.09 vs. IBES estimate USD -0.07 Q1 operating expenses USD 168.3 million Q1 operating income USD -30.7 million